It is well-established that G protein-coupled receptors (GPCRs) transduce signals into cells using G proteins as intermediary molecules. b-Arrestins are molecules involved in regulating GPCRs; however, it has recently been reported that b-arrestins can also mediate signaling through GPCRs. Signaling through G proteins or b-arrestins can be activated selectively using specific agonists; of the latter, those that can selectively activate either G proteins or b-arrestins are called biased agonists. The clinical use of biased agonists could potentially induce fewer side eŠects. However, partial agonists can also explain the mechanism of G protein-biased agonists; thus, appropriate assay systems must be considered. Endogenous agonists are known to bind to orthosteric and allosteric sites in the agonist binding site, and the allosteric site is associated with the activity of biased agonists. This current review presents a detailed discussion of biased agonists.
CITATION STYLE
Kurose, H. (2022). Biased Signaling through G Protein-coupled Receptors. Yakugaku Zasshi. Pharmaceutical Society of Japan. https://doi.org/10.1248/yakushi.22-00087
Mendeley helps you to discover research relevant for your work.